Morten Levin Rybtke

Morten Levin Rybtke is an Assistant Professor in the Department of Immunology and Microbiology at the University of Copenhagen, specializing in bacteriology with a primary focus on Pseudomonas aeruginosa biofilms. His research explores the complex interactions between bacterial biofilms and host immune systems, with particular emphasis on the molecular mechanisms governing biofilm developmental processes.

Education:

• PhD in Health Sciences from University of Copenhagen (2012), focusing on Small Molecule Signaling and Signal Inhibition in Pseudomonas aeruginosa
• MSc in Biotechnology from Technical University of Denmark (2008), specializing in Computer Based Drug Design to Combat Pseudomonas aeruginosa Infections

Rybtke's research program centers on bacterial biofilm biology, particularly investigating the impact of P. aeruginosa biofilm extracellular matrix on host immune responses, regulation of extracellular matrix production by the second messenger cyclic di-GMP, and modification of biochemical properties of the biofilm matrix. His work bridges fundamental microbiology with translational applications for treating chronic bacterial infections.

Analysis of his recent publications (2022-2025) reveals a consistent trajectory in biofilm research with increasing focus on therapeutic interventions. His work spans from fundamental biofilm mechanisms to applied research on anti-biofilm compounds and combination therapies, with particular relevance to cystic fibrosis infections and medical device-associated biofilms. The research demonstrates strong interdisciplinary collaboration across microbiology, immunology, and pharmacology domains.

Scientific Recognition:

• Active contributor to the field with 44 research outputs including 38 journal articles, 4 reviews, 1 book chapter, and 1 comment/debate
• Research has garnered significant attention with citations across Scopus and mentions in social media and news outlets

Rybtke maintains extensive collaborations with leading researchers in the biofilm field including Tolker-Nielsen, Givskov, and Høiby. His work frequently employs innovative methodologies including novel hydrogel models to study biofilm development in both in vitro and in vivo contexts, advancing our understanding of biofilm-associated infections and potential therapeutic strategies.